Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

330 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists.
Stahn C, Löwenberg M, Hommes DW, Buttgereit F. Stahn C, et al. Among authors: buttgereit f. Mol Cell Endocrinol. 2007 Sep 15;275(1-2):71-8. doi: 10.1016/j.mce.2007.05.019. Epub 2007 Jun 2. Mol Cell Endocrinol. 2007. PMID: 17630118 Review.
[Therapy of rheumatic diseases with methylprednisolone--mechanism of action and clinical applications].
Buttgereit F. Buttgereit F. Z Arztl Fortbild (Jena). 1994 Nov;88(11):897-902. Z Arztl Fortbild (Jena). 1994. PMID: 7839711 Review. German. No abstract available.
[Mechanisms of action of high-dosage glucocorticoid therapy].
Buttgereit F, Dimmeler S, Neugebauer E, Burmester GR. Buttgereit F, et al. Dtsch Med Wochenschr. 1996 Feb 23;121(8):248-52. doi: 10.1055/s-2008-1043001. Dtsch Med Wochenschr. 1996. PMID: 8815025 Review. German. No abstract available.
A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited.
Buttgereit F, Wehling M, Burmester GR. Buttgereit F, et al. Arthritis Rheum. 1998 May;41(5):761-7. doi: 10.1002/1529-0131(199805)41:5<761::AID-ART2>3.0.CO;2-M. Arthritis Rheum. 1998. PMID: 9588727 Review. No abstract available.
Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy.
Buttgereit F, Brand MD, Burmester GR. Buttgereit F, et al. Biochem Pharmacol. 1999 Jul 15;58(2):363-8. doi: 10.1016/s0006-2952(99)00090-8. Biochem Pharmacol. 1999. PMID: 10423179
Therapeutically targeting lymphocyte energy metabolism by high-dose glucocorticoids.
Buttgereit F, Burmester GR, Brand MD. Buttgereit F, et al. Biochem Pharmacol. 2000 Mar 15;59(6):597-603. doi: 10.1016/s0006-2952(99)00273-7. Biochem Pharmacol. 2000. PMID: 10677575
Bioenergetics of immune functions: fundamental and therapeutic aspects.
Buttgereit F, Burmester GR, Brand MD. Buttgereit F, et al. Immunol Today. 2000 Apr;21(4):192-9. doi: 10.1016/s0167-5699(00)01593-0. Immunol Today. 2000. PMID: 10740243 Review. No abstract available.
Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases.
Sanden S, Tripmacher R, Weltrich R, Rohde W, Hiepe F, Burmester GR, Buttgereit F. Sanden S, et al. Among authors: buttgereit f. J Rheumatol. 2000 May;27(5):1265-70. J Rheumatol. 2000. PMID: 10813299
Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease.
Schottelius A, Wedel S, Weltrich R, Rohde W, Buttgereit F, Schreiber S, Lochs H. Schottelius A, et al. Among authors: buttgereit f. Am J Gastroenterol. 2000 Aug;95(8):1994-9. doi: 10.1111/j.1572-0241.2000.02188.x. Am J Gastroenterol. 2000. PMID: 10950048
Bioenergetics of human peripheral blood mononuclear cell metabolism in quiescent, activated, and glucocorticoid-treated states.
Schmid D, Burmester GR, Tripmacher R, Kuhnke A, Buttgereit F. Schmid D, et al. Among authors: buttgereit f. Biosci Rep. 2000 Aug;20(4):289-302. doi: 10.1023/a:1026445108136. Biosci Rep. 2000. PMID: 11092251
330 results
Jump to page
Feedback